Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Skin issues can indicate immune system problems.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

New treatments are needed for non-scarring alopecia due to current limitations.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Biologics for severe asthma have known side effects, but some new risks need more study.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.